It also stimulated the anti‐tumorigenic pathway of HCC by suppressing pro‐inflammatory cytokines (IL‐6/IL‐8) and tumour angiogenesis‐related protein (NF‐κB p65) expression, indicating its potential as a therapeutic option for HCC treatment. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.